Stock Alerts on Leaders in the News: MSFT, MYL, ASTI, FSYS, CBAK, PACR
Featuring MSNB’s new video advertising; MYL’s Indian biotech partnership; market position for ASTI, FSYS, and CBAK; and PACR’s dividend.
(EMAILWIRE.COM, July 01, 2009 ) DALLAS, Texas – InvestorSoup.com announces the release of Stock Alerts covering leaders in the news: Microsoft Corp. (Nasdaq: MSFT), Mylan Inc. (Nasdaq: MYL), Ascent Solar Technologies Inc. (Nasdaq: ASTI), Fuel Systems Solutions Inc. (Nasdaq: FSYS), China BAK Battery Inc. (Nasdaq: CBAK) and Pacer International Inc. (Nasdaq: PACR).
The stock alert features the most recent headlines, share price and technical analysis for each covered company. The full alert, as well as other articles, market research and more can be found at http://www.investorsoup.com.
In the Stock Alerts, the author highlights Microsoft choosing YuMe as it's provider of target advertising:
“Microsoft Corp. (Nasdaq: MSFT) said its online news Web site MSNBC.com has chosen YuMe Inc. as the company's provider of target advertising. The Redwood City, Calif.-based YuMe Inc. will power MSNBC.com's online video. … YuMe will provide video advertising for NBC's “Nightly News” and the “Today” show, with uncommitted inventory sold as ad space. … MSNBC says the choice of YuMe gives marketers an opportunity to appeal to a wide audience as the videos can be embedded and enjoyed on their own Web sites.”
The Stock Alerts author also featured Mylan’s partnership with Biocon to develop generic biotechnology drugs:
“Mylan Inc. (Nasdaq: MYL) and India's Biocon Ltd. (BION.BO) recently announced they will collaborate to enter into the emerging market of generic biotechnology drugs. The partnership will include the development, manufacturing, supply and commercialization of ‘multiple’ generic biotechnology drugs to be sold globally. … Details of the agreement include the sharing of development, capital and related costs to the commercialization of any drug brought to market. Mylan will retain exclusive rights in the United States, Japan and Europe, and share in the profits with Biocon elsewhere. … A Mylan spokesman said the company will not disclose the particular drugs it plans to develop at this time, but said each targeted drug must have more than $1 billion in annual sales potential.”
Investors can view all of the Stock Alerts and investment articles for free by visiting:
http://www.investorsoup.com
Join the fastest growing investor community at:
http://www.stockhideout.com
Investor Soup’s Daily Soup is one of the fastest growing small cap blogs in the investment community. Investor Soup strives each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
Investor Soup.com is one of the industry’s newest and rapidly growing small-cap research providers. Investor Soup strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Investor Soup, please visit: http://www.InvestorSoup.com
InvestorSoup.com Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEB SITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and Web site have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
InvestorSoup.com is a Web site wholly owned by BlueWave Advisors, LLC. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. BlueWave Advisors LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.
Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.
We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.
To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).
We encourage you to invest carefully and read investment information available at the Web sites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
The stock alert features the most recent headlines, share price and technical analysis for each covered company. The full alert, as well as other articles, market research and more can be found at http://www.investorsoup.com.
In the Stock Alerts, the author highlights Microsoft choosing YuMe as it's provider of target advertising:
“Microsoft Corp. (Nasdaq: MSFT) said its online news Web site MSNBC.com has chosen YuMe Inc. as the company's provider of target advertising. The Redwood City, Calif.-based YuMe Inc. will power MSNBC.com's online video. … YuMe will provide video advertising for NBC's “Nightly News” and the “Today” show, with uncommitted inventory sold as ad space. … MSNBC says the choice of YuMe gives marketers an opportunity to appeal to a wide audience as the videos can be embedded and enjoyed on their own Web sites.”
The Stock Alerts author also featured Mylan’s partnership with Biocon to develop generic biotechnology drugs:
“Mylan Inc. (Nasdaq: MYL) and India's Biocon Ltd. (BION.BO) recently announced they will collaborate to enter into the emerging market of generic biotechnology drugs. The partnership will include the development, manufacturing, supply and commercialization of ‘multiple’ generic biotechnology drugs to be sold globally. … Details of the agreement include the sharing of development, capital and related costs to the commercialization of any drug brought to market. Mylan will retain exclusive rights in the United States, Japan and Europe, and share in the profits with Biocon elsewhere. … A Mylan spokesman said the company will not disclose the particular drugs it plans to develop at this time, but said each targeted drug must have more than $1 billion in annual sales potential.”
Investors can view all of the Stock Alerts and investment articles for free by visiting:
http://www.investorsoup.com
Join the fastest growing investor community at:
http://www.stockhideout.com
Investor Soup’s Daily Soup is one of the fastest growing small cap blogs in the investment community. Investor Soup strives each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
Investor Soup.com is one of the industry’s newest and rapidly growing small-cap research providers. Investor Soup strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Investor Soup, please visit: http://www.InvestorSoup.com
InvestorSoup.com Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEB SITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and Web site have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
InvestorSoup.com is a Web site wholly owned by BlueWave Advisors, LLC. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. BlueWave Advisors LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.
Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.
We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.
To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).
We encourage you to invest carefully and read investment information available at the Web sites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
|
How to buy Penny Stocks
Learn the Skills, Make the Trades, Earn a Fortune! 100% Free to try. Chartpoppers.com Stop Being Fooled By "Penny Stock Picks" Subscribe To The #1 Rated MicroCap Stock Newsletter. MicroCapster.com Analyst Penny Stock Picks Visit StockSource.us for explosive stock picks, free stock research and trading tools www.StockSource.us Your text Ads here! Ads are only $575 per month. Ads are placed same day. Contac Us Emailwire.com/contact.php |